ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE, vol.24, no.4, pp.585-593, 2015 (Journal Indexed in SCI)
Article / Article
Title of Journal :
ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE
Background. Cisplatin, an effective chemotherapeutic agent, is used for the treatment of several types of cancers. However, cisplatin has some severe side effects such as nephrotoxicity. On the other hand, molsidomine, a NO donor, has anti-oxidative and vasodilator effects.